MedTrace Logo

Comparasion of Efficacy of Nebulized With Intravenous Magnesium Sulphate in Children With Asthma

NCT04497766 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 148

Last updated 2021-02-23

No results posted yet for this study

Summary

The purpose of study is to assess the effectiveness of nebulized magnesium sulphate in children presenting with acute asthma.Study perfoma consists of demographic variables,exclusion criteria and pediatric asthma score that includes respiratory rate,SPO2 at room air(requirement of oxygen),auscultatory findings in chest,dysnea and retractions.

Conditions

  • Asthma in Children

Interventions

DRUG

Nebulized Magnesium sulfate

MgSO4 100mg in 20 ml normal saline will be given via ultrasonic nebulizer over 10 minutes,and PAS score will be assessed at 30,60,120,240,360 minutes

DRUG

Intravenous magnesium sulphate

pts age 2 to 12 years will receive intravenous magnesium sulphate 50 mg/kg over half hour

Sponsors & Collaborators

  • King Edward Medical University

    collaborator OTHER

  • Saima Khatoon

    lead OTHER

Principal Investigators

  • Muhammad-Haroon Hamid, MBBS,FCPS,FRCP · chairman /Head of department of pediatrics unit1 K.E medical university/mayo hospital l

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
2 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2020-09-30
Completion
2020-09-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04497766 on ClinicalTrials.gov